Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review
Radhakrishna Reddi Sree,
No information about this author
Manjunath Kalyan,
No information about this author
Nikhilesh Anand
No information about this author
et al.
ACS Omega,
Journal Year:
2025,
Volume and Issue:
10(6), P. 5148 - 5171
Published: Feb. 3, 2025
Alzheimer's
disease
(AD)
is
an
aging-related
irreversible
neurodegenerative
affecting
mostly
the
elderly
population.
The
main
pathological
features
of
AD
are
extracellular
Aβ
plaques
generated
by
APP
cleavage
through
amyloidogenic
pathway,
intracellular
neurofibrillary
tangles
(NFT)
resulting
from
hyperphosphorylated
tau
proteins,
and
cholinergic
neurodegeneration.
However,
actual
causes
unknown,
but
several
studies
suggest
hereditary
mutations
in
PSEN1
-2,
APOE4,
APP,
TAU
genes
major
perpetrators.
In
order
to
understand
etiology
pathogenesis
AD,
various
hypotheses
proposed.
These
include
following
hypotheses:
amyloid
accumulation,
tauopathy,
inflammation,
oxidative
stress,
mitochondrial
dysfunction,
glutamate/excitotoxicity,
deficiency,
gut
dysbiosis.
Currently
approved
therapeutic
interventions
donepezil,
galantamine,
rivastigmine,
which
cholinesterase
inhibitors
(ChEIs),
memantine,
N-methyl-d-aspartate
(NMDA)
antagonist.
treatment
strategies
focus
on
only
symptomatic
management
attenuating
symptoms
not
regeneration
neurons
or
clearance
Tau.
This
review
focuses
pathophysiology,
novel
targets,
disease-altering
treatments
such
as
α-secretase
modulators,
active
immunotherapy,
passive
natural
antioxidant
products,
nanomaterials,
antiamyloid
therapy,
aggregation
inhibitors,
transplantation
fecal
microbiota
stem
cells,
microtubule
stabilizers
that
clinical
trials
still
under
investigation.
Language: Английский
Human induced pluripotent stem cell models for Alzheimer’s disease research: a bibliometric analysis
Frontiers in Human Neuroscience,
Journal Year:
2025,
Volume and Issue:
19
Published: March 19, 2025
Alzheimer's
disease
(AD),
the
leading
cause
of
dementia,
remains
without
adequate
treatment.
Current
models
do
not
fully
replicate
human
physiology
and
pathology.
The
advent
induced
pluripotent
stem
cell
(hiPSC)
technology
offers
a
novel
approach
to
studying
AD.
Our
study
conducted
bibliometric
analysis
assess
application
development
hiPSC
in
AD
research.
We
retrieved
531
articles
on
from
Web
Science
Core
Collection,
published
between
January
2010
June
2024.
CiteSpace
VOSviewer
were
used
analyze
authorship,
geographic
contributions,
journal
influence,
citation
patterns.
findings
reveal
steady
increase
publications
over
14
years,
with
United
States
followed
by
China.
Li-Huei
Tsai
Massachusetts
Institute
Technology
is
prominent
researcher.
PLoS
One
emerges
as
most
influential
journal.
Research
trends
have
focused
inflammation,
astrocytes,
microglia,
apolipoprotein
E
(ApoE),
tau.
Bibliometric
crucial
identifying
research
gaps
guiding
future
studies
address
unmet
needs
understanding
modeling
Leveraging
investigate
molecular
mechanisms
familial
sporadic
expected
provide
foundation
for
developing
treatment
strategies.
In
summary,
this
comprehensive
overview
current
landscape
It
also
highlights
emerging
gaps,
efforts,
particularly
exploring
therapeutic
targets
improving
mechanisms.
Language: Английский
Advances and New Therapies in Traumatic Spinal Cord Injury
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(7), P. 2203 - 2203
Published: March 24, 2025
Recovery
from
traumatic
spinal
cord
injury
(tSCI)
is
challenging
due
to
the
limited
regenerative
capacity
of
central
nervous
system
restore
cells,
myelin,
and
neural
connections.
At
clinical
level,
fundamental
pillars
treatment
are
reduction
in
secondary
damage
(neuroprotection)
rehabilitation;
these
tools
we
have
mitigate
disability
caused
by
(SCI).
To
date,
treatments
on
which
neuroprotection
has
been
based
prevention
acute
respiratory
failure
avoid
hypoxia,
early
hemodynamic
control,
neuroprotective
drugs
surgical
management.
Optimizing
control
ensure
adequate
perfusion
may
be
key
management
SCI.
While
agents
like
methylprednisolone
fallen
into
disuse,
several
promising
therapies
currently
being
tested
trials.
In
terms
treatment,
although
their
impact
neurological
recovery
remains
debated,
appropriate
bone
decompression
followed
duroplasty
selected
cases
increasingly
recommended.
Advances
cell
hold
significant
potential
for
enhancing
both
functional
outcomes
SCI
patients.
Moreover,
emerging
neuromodulation
techniques,
such
as
transcutaneous
epidural
stimulation,
along
with
innovations
rehabilitation
technologies-such
robotic
systems
exoskeletons-are
becoming
indispensable
improving
locomotion
overall
mobility
individuals
This
article
provides
an
update
advances
against
tSCI,
cellular
therapies,
new
therapies.
Language: Английский
Drug repurposing for neurodegenerative diseases
Halak Shukla,
No information about this author
D. James B. St. John,
No information about this author
Shuvomoy Banerjee
No information about this author
et al.
Progress in molecular biology and translational science,
Journal Year:
2024,
Volume and Issue:
unknown, P. 249 - 319
Published: Jan. 1, 2024
Language: Английский
The Neuroanatomy of Induced Pluripotent Stem Cells: In Vitro Models of Subcortical Nuclei in Neurodegenerative Disorders
Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(9), P. 10180 - 10199
Published: Sept. 14, 2024
Neuromodulatory
subcortical
systems
(NSSs)
are
monoaminergic
and
cholinergic
neuronal
groups
that
markedly
precociously
involved
in
the
pathogenesis
of
many
neurodegenerative
disorders
(NDDs),
including
Parkinson’s
Alzheimer’s
diseases.
In
humans,
although
tools
have
been
developed
to
infer
information
on
these
nuclei,
encompassing
neuroimaging
neurophysiological
methods,
a
detailed
specific
direct
evaluation
their
cellular
features
vivo
has
difficult
obtain
until
recent
years.
The
development
induced
pluripotent
stem
cell
(iPSC)
models
allowed
research
deeply
delve
into
molecular
biology
NSS
neurons.
fact,
iPSCs
can
be
produced
easily
non-invasively
from
patients’
fibroblasts
or
circulating
blood
monocytes,
by
de-differentiating
those
cells
using
protocols,
then
re-differentiated
towards
neural
phenotypes,
which
may
reproduce
correspondent
brain
neurons
(including
ones)
same
patient.
this
review,
we
summarized
findings
obtained
field
NDDs
iPSCs,
with
aim
understand
how
reliably
might
represent
vitro
NSS.
We
found
most
current
literature
NSSs
focused
midbrain
dopaminergic
disease,
providing
interesting
results
pathophysiology
even
leading
first
human
autologous
transplantation.
Differentiation
protocols
for
noradrenergic,
cholinergic,
serotoninergic
also
recently
defined
published.
Thus,
it
expected
near
future,
approach
could
extend
other
NDDs.
Language: Английский
Induced pluripotent stem cells derived renal tubular cells from a patient with pseudohypoparathyroidism and its response to parathyroid hormone stimulation
Molecular Biology Reports,
Journal Year:
2024,
Volume and Issue:
51(1)
Published: July 11, 2024
Language: Английский
Role of NF-κB signaling pathway in H2O2-induced oxidative stress of hiPSCs
Qin Jian,
No information about this author
Jie Yang,
No information about this author
Weiwei Li
No information about this author
et al.
In Vitro Cellular & Developmental Biology - Animal,
Journal Year:
2024,
Volume and Issue:
60(9), P. 1021 - 1033
Published: Aug. 12, 2024
Language: Английский
Advances in induced pluripotent stem cell-based in vitro disease modeling for rare neurodegenerative disease: A narrative review
Seung‐Yeon Lee,
No information about this author
Hyo Jin Son,
No information about this author
Sang Won Seo
No information about this author
et al.
Precision and Future Medicine,
Journal Year:
2024,
Volume and Issue:
8(3), P. 65 - 73
Published: Sept. 6, 2024
Understanding
the
genetic
basis
and
pathomechanisms
underlying
dementia
arising
from
single-gene
mutations
is
crucial
to
expand
our
knowledge
in
field
of
research.
In
this
review,
we
comprehensively
summarize
results
existing
research
using
induced
pluripotent
stem
cells
(iPSCs)
investigate
familial
Alzheimer’s
disease
caused
by
presenilin-1
(PSEN1),
presenilin-2
(PSEN2),
or
amyloid
precursor
protein
(APP)
genes.
We
further
review
iPSC
studies
leukodystrophies,
including
Cerebral
Autosomal
Dominant
Arteriopathy
with
Subcortical
Infarcts
Leukoencephalopathy
(CADASIL),
notch
receptor
3
(NOTCH3)
gene;
adult-onset
leukoencephalopathy
axonal
spheroids
pigmented
glia
(ALSP),
colony-stimulating
factor
1
(CSF1R)
gene.
systematically
advantages
necessity
iPSCs
elucidate
pathogenesis
neurodegenerative
diseases,
particularly
facilitate
modeling.
Furthermore,
introduce
applied
based
on
technology.
Through
aimed
help
mechanisms
which
causative
genes
induce
symptoms
would
contribute
development
effective
treatment
strategies.
Language: Английский
Brain tumors and induced pluripotent stem cell technology: a systematic review of the literature
Monir Shayestehfar,
No information about this author
Tina Taherkhani,
No information about this author
Pardis Jahandideh
No information about this author
et al.
Annals of Medicine and Surgery,
Journal Year:
2024,
Volume and Issue:
87(1), P. 250 - 264
Published: Dec. 11, 2024
Induced
pluripotent
stem
cells
(iPSCs)
provide
a
novel
approach
to
studying
the
pathophysiology
of
brain
tumors
and
assessing
various
therapeutic
techniques
with
greater
precision.
This
study
aims
systematically
review
existing
literature
critically
analyze
synthesize
current
research
findings.
The
objective
is
evaluate
role
iPSCs
in
understanding
development
innovative
treatment
strategies.
We
reviewed
articles
that
utilized
iPSC
technology
assess
either
or
techniques,
following
standards
Preferred
Reporting
Items
for
Systematic
Meta-Analysis
guidelines.
Key
terms
were
comprehensively
searched
electronic
databases,
including
PubMed,
EMBASE,
Scopus.
Articles
screened
based
on
specific
inclusion
exclusion
criteria.
Ultimately,
22
relevant
chosen,
their
data
extracted.
summary
findings
each
selected
article
was
organized
into
two
general
categories:
"Methods
Generating
iPSCs"
"Applications
iPSCs."
methods
generation,
transfection
transduction,
as
well
types
viral
non-viral
vectors
used,
extracted
reported
study.
Additionally,
main
studies,
whether
modeling
approaches,
gathered
results
section.
vehicle
brings
new
solutions
overcome
difficulties
tumor
studies.
In
vivo
vitro
models
generated
from
suitable
platforms
investigate
more
precisely.
Also,
have
been
studies
examine
how
different
antitumor
agents
may
affect
target
cells.
Language: Английский
Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture
Nousheen Zahoor,
No information about this author
Areej Arif,
No information about this author
Muhammad Shuaib
No information about this author
et al.
Veterinary Sciences,
Journal Year:
2024,
Volume and Issue:
11(12), P. 666 - 666
Published: Dec. 19, 2024
The
only
cells
in
an
organism
that
could
do
any
other
sort
of
cell
until
2006
(except
sperm
or
egg)
were
known
as
embryonic
stem
cells,
ESC
[...]
Language: Английский